Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 184 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: No Conditions Clear all

Conditions: Hepatitis C, Chronic
Interventions: Epclusa (SOF/VEL), Standard of care, Fibroscan® 430 Mini Plus; Drug · Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 64 Years
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Thrombotic Thrombocytopenic Purpura (TTP)
Interventions: TAK-755; Biological
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 12
States / cities: Gainesville, Florida • Boston, Massachusetts • Minneapolis, Minnesota + 7 more

Conditions: No Disease or Condition is Being Directly Studied, The Focus of the Study in Healthy Volunteers
Interventions: Osteopathic Manipulative Treatment, Sham; Other
Lead sponsor: Lake Erie College of Osteopathic Medicine; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Erie, Pennsylvania

Conditions: Osteoarthritis, Knee, Pain
Interventions: CGS-200-1, CGS-200-5, CGS-200 Vehicle; Drug
Lead sponsor: Propella Therapeutics; Industry
Eligibility: 35 Years to 75 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 6
States / cities: Clearwater, Florida • Tampa, Florida • Cincinnati, Ohio + 2 more

Conditions: Barrett Esophagus, Intestinal Metaplasia, Esophageal Dysplasia
Interventions: CryoBalloon Focal Ablation System; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 11
States / cities: Birmingham, Alabama • Washington D.C., District of Columbia • Baltimore, Maryland + 8 more

Conditions: No Specific Medical Conditions or Disease States
Interventions: Telemetry monitoring, Continuous monitoring through Earlysense, Continuous monitoring through Dozee VS; Device
Lead sponsor: Turtle Shell Technologies Pvt. Ltd.; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Redmond, Washington

Conditions: Postoperative Pain
Interventions: root canal treatment, anesthesia, pain medications, and antibiotic, no root canal treatment, anesthesia, pain medications, and antibiotic; Procedure
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Solid Tumors, CNS Tumors
Interventions: Entrectinib; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 0 Years to 18 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 15
States / cities: La Jolla, California • San Francisco, California • Aurora, Colorado + 12 more

Conditions: Surgical Site Infection, Superficial Surgical Site Infection, Deep Surgical Site Infection, Organ/Space Surgical Site Infection
Interventions: Hair clipping; Procedure
Lead sponsor: Gundersen Lutheran Medical Foundation; Other
Eligibility: 18 Years and older
Enrollment: 1,678 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: La Crosse, Wisconsin

Conditions: Individual, Category, and No-label Conditions
Interventions: Effects of shared book reading: Labels; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 5 Months to 65 Years
Enrollment: 146 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Healthy, Physiology
Interventions: Definity, Exercise, Kidney Ultrasound; Drug · Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 50 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Rectal Prolapse
Interventions: sacral rectopexy with sutures or meshes, full rectal mobilization from the sacrum without sacral rectopexy; Procedure
Lead sponsor: Societa Italiana di Chirurgia ColoRettale; Network
Eligibility: 18 Years to 70 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Hormone Receptor Positive Breast Cancer
Interventions: faslodex 500mg, arimidex 1mg, faslodex dummy, arimidex dummy; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years · Female only
Enrollment: 462 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2026
U.S. locations: 12
States / cities: Modesto, California • Savannah, Georgia • Auburn, Maine + 9 more

Conditions: Colorectal Cancer, Healthy, no Evidence of Disease, Precancerous Condition
Interventions: gene expression analysis, polymerase chain reaction, polymorphism analysis, protein expression analysis, proteomic profiling, gas chromatography, laboratory biomarker analysis, liquid chromatography, mass spectrometry, questionnaire administration; Genetic · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 551 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Infection, Bacterial Infection, Sepsis
Interventions: Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor; Device
Lead sponsor: Brahms AG; Industry
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 3
States / cities: St Louis, Missouri • Camden, New Jersey • Providence, Rhode Island

Conditions: No Specific Medical Conditions or Disease States
Interventions: Telemetry monitoring; Device
Lead sponsor: Turtle Shell Technologies Pvt. Ltd.; Industry
Eligibility: 22 Years to 100 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Lake Jackson, Texas

Conditions: Hernia
Interventions: Metallic Fasteners and Sutures, Metallic Fasteners Alone; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: There is no Focus on Any Specific Condition
Interventions: Peripheral intravenous catheter placement, Blood draw, Peripheral intravenous catheter, To keep open (TKO) infusion of 0.9% normal saline; Procedure · Other · Device + 1 more
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 90 Years
Enrollment: 230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Chronic Limb Threatening Ischemia
Interventions: Transverse Tibial Bone Transport, TrueLok Elevate; Procedure · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 95 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: No Disease State or Condition
Interventions: Nutritional Messaging; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Austin, Minnesota

Conditions: Arrhythmias, Cardiac
Interventions: CanGaroo Envelope; Device
Lead sponsor: Elutia Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 23
States / cities: Little Rock, Arkansas • Daytona Beach, Florida • Delray Beach, Florida + 20 more

Conditions: No Condition, Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG
Interventions: Virtual human social interaction, Cold pressor test; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Downey, California • Los Angeles, California

Conditions: No Disease or Condition is Being Studied
Interventions: Esports Ergonomic Protocol; Other
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: No Specific Condition
Interventions: Telephone Visit; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study

A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

The Effect of Osteopathic Manipulative Techniques on Human Tear Composition

A Phase 2 Clinical Trial Examining the Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5 and Vehicle Control

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

Pilot Evaluation of an Continuous Contactless Vitals Parameter Monitoring System Dozee VS

Effect of Root Canal Treatment (Versus no Treatment) for Patients With Tooth Infections and Toothaches

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Clipping Versus No Hair Removal and the Risk of Surgical Site Infections

Infant and Parent Shared Book Reading

Assessment of the Changes in Cortical and Medullary Renal Blood Flow During Exercise in Healthy Subjects Using Contrast Enhanced Ultrasound

Pexy Versus Non-pexy for Full Thickness Rectal Prolapse

A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.

Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps

Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection

Dozee Validation for Contactless Heart Rate and Respiration Monitoring in Clinical Settings

Hernia Repair With or Without Sutures

Antegrade Versus Retrograde IV for Blood Draws

Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)

Nutritional Language Model

CanGaroo® Registry Study

Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States

Ergonomic Protocol for Competitive E-Sport Athletes

Feasibility of Telephone Follow-up Visits in Primary Care